Q4 2023

Source filing unavailable

Q4 2023 · —

derived · Computed from the longer spans the company filed.

Revenue—

Net income—

EPS, diluted—Not derived. Share counts vary by quarter.

Operating Cash Flowderived-$7,091,000—

Free Cash Flowderived-$7,111,000—

Same quarter

no prior Q4 2022 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Adagio Medical Holdings, Inc. · CIK 2006986 · Engraved from SEC EDGAR